| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/24/2011 | CN102164896A Phenethylamide derivatives and their heterocyclic analogues |
| 08/24/2011 | CN102164894A Heteroaryl antagonists of prostaglandin D2 receptors |
| 08/24/2011 | CN102164891A Substituted 1,2,3,4- tetrahydrocyclopenta[b]indol-3-yl) acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
| 08/24/2011 | CN102164890A Polymorphic form of calcium acamprosate |
| 08/24/2011 | CN102164888A Deacetylase inhibitors and uses thereof |
| 08/24/2011 | CN102164887A Halogenated analogues of anti-fibrotic agents |
| 08/24/2011 | CN102164886A Process for the preparation of O-desmethylvenlafaxine |
| 08/24/2011 | CN102164884A Hydroxybutyrate ester and medical use thereof |
| 08/24/2011 | CN102164638A Use of histone deacetylase inhibitors for the care of philadelphia-negative myeloproliferative syndromes |
| 08/24/2011 | CN102164615A Drug sustained release agent, adsorbent, functional food, mask, and adsorptive sheet |
| 08/24/2011 | CN102164606A Light-stabilized pharmaceutical composition |
| 08/24/2011 | CN102164605A Inhibitors of the plasmodial surface anion channel as antimalarials |
| 08/24/2011 | CN102164604A Fused heterocyclic compounds useful as kinase modulators |
| 08/24/2011 | CN102164603A Methods and kits for treating cluster headache disorders |
| 08/24/2011 | CN102164602A Synergistic combinations of a macrocyclic inhibitor of HCV and a nucleoside |
| 08/24/2011 | CN102164601A Transdermal extended-delivery donepezil compositions and methods for using the same |
| 08/24/2011 | CN102164600A Ophthalmic pharmaceutical compositions comprising sorafenib for the treatment of neoangiogenic pathologies of the eye |
| 08/24/2011 | CN102164599A Prophylactic and/or therapeutic agent for functional gastrointestinal disorders |
| 08/24/2011 | CN102164598A Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system |
| 08/24/2011 | CN102164597A Sustained release formulations using non-aqueous carriers |
| 08/24/2011 | CN102164596A Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient |
| 08/24/2011 | CN102164595A Nutritional support of the immune system during anti-cancer treatment |
| 08/24/2011 | CN102164594A Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs |
| 08/24/2011 | CN102164593A Therapeutic replenishment and enrichment of ocular surface lubrication |
| 08/24/2011 | CN102164592A Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders |
| 08/24/2011 | CN102164591A Combinations of a rate control agent and an A-2-alpha receptor antagonist for use in multidetector computed tomography methods |
| 08/24/2011 | CN102164590A Therapeutic agent for tympanites in ruminant animal |
| 08/24/2011 | CN102164589A PH-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol |
| 08/24/2011 | CN102164588A PH-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol |
| 08/24/2011 | CN102164587A Dosage units of 3-(6-(1-(2,2-difluorobenzo [D] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 08/24/2011 | CN102164585A Compositions comrrising amlodipine and bisoprolol |
| 08/24/2011 | CN102164584A Galenical formulation comprising aliskiren and process for its preparation by melt extrusion granulation |
| 08/24/2011 | CN102164579A Liquid formulations of bendamustine |
| 08/24/2011 | CN102164562A Coating with antimicrobial agents |
| 08/24/2011 | CN102164488A Novel compounds advantageous in the treatment of central nervous system diseases and disorders |
| 08/24/2011 | CN102161710A Method for preparing tremellan with low molecular weight and novel medicinal application thereof |
| 08/24/2011 | CN102161690A Betulonic acid derivative for preparing medicine used for resisting osteoporosis as well as preparation method and application thereof |
| 08/24/2011 | CN102161680A Phosphamide ester camptothecin derivative as well as preparation method, pharmaceutical composition and usage thereof |
| 08/24/2011 | CN102161679A Compositions and methods for treating cancer |
| 08/24/2011 | CN102161668A Preparation method of oxacillin sodium and oxacillin sodium for injection |
| 08/24/2011 | CN102161667A Sulbenicillin sodium and sulbenicillin sodium used for injection |
| 08/24/2011 | CN102161663A Inhibitors of protein tyrosine kinase activity |
| 08/24/2011 | CN102161658A N-(naphthoxyalkyl)heteroarylpiperidine compounds and preparation method and applications thereof |
| 08/24/2011 | CN102161656A Caspase inhibitors and uses thereof |
| 08/24/2011 | CN102161655A Apigenin derivatives and preparation method and applications thereof |
| 08/24/2011 | CN102161653A Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof |
| 08/24/2011 | CN102161650A Polyphenol secondary metabolic products in mulberry leaves and preparation method and application thereof |
| 08/24/2011 | CN102161649A Polyphenol type derivatives extracted from mulberry leaves and preparation method and applications thereof |
| 08/24/2011 | CN102161648A Preparation method and applications of isoflavone type compounds with selective estrogen receptor modulating activity |
| 08/24/2011 | CN102161647A Preparation method and applications of isoflavone type multidrug resistance reversal agent of cancer cell |
| 08/24/2011 | CN102161644A Ligands for g-protein coupled receptors |
| 08/24/2011 | CN102161643A Heterocyclic carboxylic acid derivative and application as endothelin receptor antagonist thereof |
| 08/24/2011 | CN102161627A Omega-(N-substituted-aminoalkyl)octanamide |
| 08/24/2011 | CN102161619A Ferulic acid Jiangtang compound salt as well as preparation method and application thereof |
| 08/24/2011 | CN102160887A Medicament for treating gynecological inflammation and preparation method thereof |
| 08/24/2011 | CN102160886A Compound buccal tablet containing sodium azulene sulfonate and application |
| 08/24/2011 | CN102160878A Chinese medicinal ointment preparation for treating hemorrhoids |
| 08/24/2011 | CN102160875A Blood-nourishing skin-moisturizing health product |
| 08/24/2011 | CN102160872A Compound salvia dropping pill capsules |
| 08/24/2011 | CN102160870A Application of poly(4-styrenesulfonic acid-co-maleic acid) sodium and medicinal composition thereof |
| 08/24/2011 | CN102160869A Application of eleutheroside E in preparing medicines for resisting central fatigue |
| 08/24/2011 | CN102160868A Application of astragaloside IV in preparing liver cancer resisting medicines |
| 08/24/2011 | CN102160867A Application of astragaloside II in preparing anti-cancer medicines |
| 08/24/2011 | CN102160866A Application of tanshinone IIA or pharmaceutically acceptable salts thereof in preparing medicines for treating or preventing pulmonary hypertension disease |
| 08/24/2011 | CN102160865A Compositions of r(+) and s(-) pramipexole and methods of using the same |
| 08/24/2011 | CN102160864A Improved cancer treatment with temozolomide |
| 08/24/2011 | CN102160863A Purification preparation method of isoalantolactone and application of isoalantolactone in preparation of anti-tumor drugs |
| 08/24/2011 | CN102160862A Antiobesity agent and pharmaceutical, food, or cosmetic provided with fat accumulation inhibiting effect |
| 08/24/2011 | CN102160861A Infusion medicament analgesic patch |
| 08/24/2011 | CN102160860A Medicament for promoting hair growth and preventing hair loss and preparation method thereof |
| 08/24/2011 | CN102160859A Loratadine and pseudoephedrine compound slow-release medicament |
| 08/24/2011 | CN102160857A Methylphenidate patch |
| 08/24/2011 | CN102160855A Dex-ibuprofen sustained release tablets and preparation method thereof |
| 08/24/2011 | CN102160854A Cyclodextrin-included florfenicol quick-release water-soluble powder preparation and preparation method thereof |
| 08/24/2011 | CN102160853A Vinpocetine injection and preparation method thereof |
| 08/24/2011 | CN102160852A Ibuprofen injection and preparation method thereof |
| 08/24/2011 | CN102160851A Ibuprofen injection and preparation method thereof |
| 08/24/2011 | CN102160685A Atomized caffeine and atomization method |
| 08/24/2011 | CN102160651A Stabilized formulations of phosphatidylserine |
| 08/24/2011 | CN102160650A Food containing glycine and use thereof |
| 08/24/2011 | CN102160648A Rapidly disintegrating calcium tablets and preparation method thereof |
| 08/24/2011 | CN101874873B Traditional Chinese medicine for treating tumors |
| 08/24/2011 | CN101836975B Application of isopentene group flavonoid compound used as pancreatic lipase inhibitor |
| 08/24/2011 | CN101810766B Chinese medicinal composition and preparation method and application thereof |
| 08/24/2011 | CN101804060B Microsphere injection of ceftriaxone sodium/tazobactam sodium drug composition |
| 08/24/2011 | CN101791356B Chinese medicine for treating herpes zoster |
| 08/24/2011 | CN101773602B Epimedium kidney-tonifying wine |
| 08/24/2011 | CN101766619B Pharmaceutical composition for malignancy treatment and application thereof |
| 08/24/2011 | CN101747446B Method for extracting anti-fatigue acidic ginseng polysaccharide |
| 08/24/2011 | CN101744832B Chinese traditional medicine preparation for reversing multiple medicine resistance of tumor cells and preparation method thereof |
| 08/24/2011 | CN101724089B Acidic aloe polysaccharide as well as preparation and purification method and application thereof |
| 08/24/2011 | CN101721382B Lansoprazole submicron emulsion solid preparation and novel application thereof |
| 08/24/2011 | CN101711743B Febuxostat dry suspension and preparation method thereof |
| 08/24/2011 | CN101703497B Application of Chlorogenic acid in preparing drug having protection and restoration functions on spleen hematopoietic stem cell injuries |
| 08/24/2011 | CN101693022B Method for preparing resveratrol sustained-release capsule capable of preventing rheumatoid arthritis |
| 08/24/2011 | CN101690750B External medicine for curing hyperosteogeny |
| 08/24/2011 | CN101669947B Application of bis (5-butyl-2-picolinic acid-N1,O2) copper (II) for preparing anti-tuberculosis drugs |
| 08/24/2011 | CN101642433B Nimesulide liposome solid preparation and preparation method of drug composite thereof |
| 08/24/2011 | CN101579313B Cefalexin liposome and medicinal composition thereof |
| 08/24/2011 | CN101554449B Traditional Chinese medicine for traumatic curing |